FindTrial
Sign In

Study of iron treatment in delivered women with anemia

A COMPARATIVE STUDY OF IRON ISOMALTOSIDE VERSUS IRON SUCROSE IN TREATING ANEMIA IN POST-PARTUM PERIOD - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065651
Enrollment
216
Registered
2024-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O908- Other complications of the puerperium, not elsewhere classified

Interventions

Intervention1: INJ IRON ISOMALTOSE: GROUP 1 INJ IRON ISOMALTOSE IV INFUSION SHALL BE GIVEN OVER 20-30 MINUTES Control Intervention1: INTRAVENOUS IRON THHERAPY INJ IRON ISOMALTOSIDE: GROUP 1-INJ IRON I

Sponsors

DR PRAJAKTA BHOSLE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Post Partum women on day 1 to day 10 following vaginal or cesarean section Postnatal Women with Hemoglobin less than 10mg/dl

Exclusion criteria

Exclusion criteria: Women having Anaemia other than iron deficiency anemia women with haemoglobinopathies women having past history ofhypersensitivity reaction or allergic reactions to perenteral iron

Design outcomes

Primary

MeasureTime frame
SAFE AND COST EFFECTIVE INTRAVENOUS IRON THERAPY IN POSTPARTUM PERIOD WITH IN 3 WEEKS OF DELIVERY, MEAN HAEMOGLOBIN AND SERUM FERRITIN SHALL BE ASSESSEDTimepoint: AFTER 1 WEEK AND 3 WEEKS OF TREATMENT—

Secondary

MeasureTime frame
ANY INCOMPATIBILITY OF SPECIFIC IRON THERAPY AT THE TIME AND IN 1 WEEK OF THERAPYTimepoint: AT THE TIME OF TREATMENT AND AFTER 1 WEEK AND THREE WEEKS OF TREATMENT—

Countries

India

Contacts

Public ContactDR PRAJAKTA BHOSLE

SHRI B M PATIL MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTER

drsrbidri1@gmail.com9880162550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026